Form 8-K VERTEX PHARMACEUTICALS For: Oct 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Vertex (VRTX) PT Raised to $235 at RBC Capital
October 31, 2019 6:39 AM EDTRBC Capital analyst Brian Abrahams raised the price target on Vertex (NASDAQ: VRTX) to $235.00 (from $210.00) while maintaining an Outperform rating.
The analyst commented, "Overall, an in-line quarter with continued solid commercial execution on the CF franchise and pipeline remaining on track -- which despite... More
